Generex Biotechnology Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Haines Harold Gray, was filed 14 Dec 2018.
Generex Biotechnology Corp: what insiders have been doing
Generex Biotechnology Corp is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Generex Biotechnology Corp in twelve months, the latest record being from 14 December 2018.
The full history, which starts in 2006, counts 21 purchases against 9 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended July 2019 · cache
- 300 shares@ US$1.032.6% of flowCommon StockSEC:0001761913-18-000001:0Canonical exit: 7 Mar 2019 (T+90)
- 8,000 shares@ US$1.0570.7% of flowCommon StockSEC:0001761913-18-000001:1Canonical exit: 7 Mar 2019 (T+90)
- 555 shares@ US$2.109.8% of flowCommon StockSEC:0001761913-18-000002:0Canonical exit: 4 Mar 2019 (T+90)
- 945 shares@ US$2.1216.9% of flowCommon StockSEC:0001761913-18-000002:1Canonical exit: 4 Mar 2019 (T+90)
- 1,667,671 sharesCommon StockSEC:0001607062-16-000684:0
- 4,447,111 sharesCommon StockSEC:0001607062-16-000682:0
- 5,583,775 sharesCommon StockSEC:0001607062-16-000655:0
- 14,890,033 sharesCommon StockSEC:0001607062-16-000653:0
- 5,874,162 shares0Common StockSEC:0001607062-15-000187:0
- 35,714 shares0Common StockSEC:0001363585-14-000002:0
- 470,726 shares0Common StockSEC:0001363585-14-000003:0
- 35,714 shares0Common StockSEC:0001363585-14-000001:0
- 2,524,164 shares@ US$0.0355Common StockSEC:0001363585-13-000016:0
- 2,524,164 shares0Common StockSEC:0001363585-13-000013:0
- 508,197 shares0Common StockSEC:0001363585-12-000012:0
- 546,448 shares@ US$0.0922Common StockSEC:0001363585-12-000010:0
- 546,448 shares0Common StockSEC:0001363585-12-000008:0
- 15,000 shares@ US$0.23Common StockSEC:0001144204-11-027954:0
- 20,000 shares@ US$0.225Common StockSEC:0001144204-11-027214:0
- 25,000 shares@ US$0.22Common StockSEC:0001144204-11-026245:0
- 20,000 shares@ US$0.239Common StockSEC:0001144204-11-020631:0Canonical exit: 5 Jul 2011 (T+90)
- 576,752 shares0Common StockSEC:0001144204-11-000211:0
- 54,000 shares@ US$0.35Common StockSEC:0001144204-10-055794:0Canonical exit: 25 Jan 2011 (T+90)
- 8,700 shares@ US$0.52Common StockSEC:0001144204-10-000079:0Canonical exit: 4 Apr 2010 (T+90)
- 10,000 shares@ US$0.51Common StockSEC:0001144204-09-059725:0Canonical exit: 14 Feb 2010 (T+90)
25 of 54 declarations
About Generex Biotechnology Corp
Generex Biotechnology Corp is a company focused on developing therapeutic solutions for the treatment of diabetes and other diseases. It is listed on NASDAQ under the symbol XNAS.
